Association between 5-lipoxygenase expression and plaque instability in humans.
about
Emerging Comorbidities in Adult Asthma: Risks, Clinical Associations, and MechanismsCysteinyl Leukotrienes and Their Receptors: Emerging Therapeutic Targets in Central Nervous System Disorders5-Lipoxygenase Gene Variants Are Not Associated With Atherosclerosis or Incident Coronary Heart Disease in the Multi-Ethnic Study of Atherosclerosis CohortOxidative risk for atherothrombotic cardiovascular disease.Common polymorphisms of ALOX5 and ALOX5AP and risk of coronary artery disease.Potential role of the lipoxygenase derived lipid mediators in atherosclerosis: leukotrienes, lipoxins and resolvins.High prevalence of human cytomegalovirus in carotid atherosclerotic plaques obtained from Russian patients undergoing carotid endarterectomyGenotyping the GGGCGG tandem repeat promoter polymorphism in the 5-lipoxygenase enzyme gene (ALOX5) by pyrosequencing assay.Expression of 5-lipoxygenase and leukotriene A4 hydrolase in human atherosclerotic lesions correlates with symptoms of plaque instability.Complex inheritance of the 5-lipoxygenase locus influencing atherosclerosis in miceReactive oxygen species in cardiovascular disease.Leukotriene B4 receptor-1 mediates intermittent hypoxia-induced atherogenesis.EETs Attenuate Ox-LDL-Induced LTB4 Production and Activity by Inhibiting p38 MAPK Phosphorylation and 5-LO/BLT1 Receptor Expression in Rat Pulmonary Arterial Endothelial Cells.Common Polymorphisms in the 5-Lipoxygenase Pathway and Risk of Incident Myocardial Infarction: A Danish Case-Cohort Study.Overview of the pharmacogenetics of asthma treatment.Adipose tissue arachidonic acid content is associated with the expression of 5-lipoxygenase in atherosclerotic plaques.Leukotriene receptors in atherosclerosis.The potential link between atherosclerosis and the 5-lipoxygenase pathway: investigational agents with new implications for the cardiovascular field.Leukotriene signaling in atherosclerosis and ischemiaGenetic effects in the leukotriene biosynthesis pathway and association with atherosclerosis.Leukotriene B4 levels in human atherosclerotic plaques and abdominal aortic aneurysms.Anti-inflammatory therapeutics for the treatment of atherosclerosis.5-Lipoxygenase inhibitors: a review of recent developments and patents.Eicosanoids and their drugs in cardiovascular diseases: focus on atherosclerosis and stroke.Emerging anti-inflammatory drugs for atherosclerosis.Arterial inflammation in bronchial asthma.Anti-HMG-CoA Reductase, Antioxidant, and Anti-Inflammatory Activities of Amaranthus viridis Leaf Extract as a Potential Treatment for Hypercholesterolemia.Role of the Cysteinyl Leukotrienes in the Pathogenesis and Progression of Cardiovascular Diseases.Expression Profiling of Genes Related to Endothelial Cells Biology in Patients with Type 2 Diabetes and Patients with Prediabetes.Influence of aspirin on SR-BI expression in human carotid plaques.Association of ALOX5, LTA4H and LTC4S gene polymorphisms with ischemic stroke risk in a cohort of Chinese in east China.Lipoxygenase and prostaglandin G/H synthase cascades in cardiovascular disease.5-lipoxygenase inhibitor zileuton attenuates ischemic brain damage: involvement of matrix metalloproteinase 9.Leptin induces macrophage lipid body formation by a phosphatidylinositol 3-kinase- and mammalian target of rapamycin-dependent mechanism.Initial Clinical Experience with AZD5718, a Novel Once Daily Oral 5-Lipoxygenase Activating Protein Inhibitor.Impact of inflammation, gene variants, and cigarette smoking on coronary artery disease riskResearch Progress on the Relationship between Atherosclerosis and Inflammation
P2860
Q26747066-09E5035F-E276-49EA-940A-EB61E03FC95BQ28278005-F84AB6EF-B9D8-4696-B51F-949CE4333BA1Q30277078-66C0743C-B8B6-4DD1-9A84-F09E74965D63Q33554184-71BE485F-7DE8-47EE-B5B5-A9897CB74942Q33622665-E8AB0226-D5B9-442E-9B0C-AD98583D5151Q34113615-15B47DC4-2044-4EDB-A6A6-F4A63254B41BQ34253980-4D88886A-3B4B-4006-B539-4E717A48FDD9Q34385384-7975EE70-E2B7-4E79-8DCA-3FB92E1C3C30Q34601356-0A71A346-7C89-4D3C-A6ED-DA9A774A877FQ34895911-30AC7620-2804-4FAF-992E-B255E7A2866CQ35165194-87CC15E4-FE2A-4832-A71A-0BB5D389E192Q35212608-2BFBC07C-674A-41D8-B3EF-873F33E3C73AQ35649907-0DB10E75-04CD-4E9D-BEAA-264F0147FB60Q36205625-2DCE3A99-C8EA-472C-9527-7CE1C6531AAAQ36433595-D6AB162E-7A38-4064-8B53-92C9612FFDE3Q36578662-0C404EEE-A671-4564-ACED-4B2040065354Q36652544-FCEFE3CC-53F7-415F-A14D-7222B8821804Q37016080-1A862C63-0AC8-4CCA-BA22-4084717AD987Q37145833-2E533339-695A-4826-93A6-B224EDFA27ACQ37380468-BAA27C99-F3A0-4457-B894-7E2488ACF7E1Q37520764-920F936D-0BFD-4487-9DF2-901C2BD85F2CQ37626768-E7887614-3D2F-4A4C-8D03-DA1E037BBEA0Q37697795-3AB7D392-D199-4FCD-96C9-24C24A05AF28Q37995534-E72C498D-001A-4E4A-A85B-99AD901AC38BQ38106998-88B03972-F94A-4C33-8550-5EFE328381E4Q38454054-6CC2874E-5DFD-4748-B22C-C50FC51993E4Q39372300-2F14B54E-B427-44C0-BBC3-C8B16D852C1AQ41432422-8186D377-7681-4472-90B5-B02AD1401DA9Q41984090-151371AA-4DCF-47F0-9C8E-83485A2D6CFAQ42098692-5E28EEEB-A52D-4247-8187-49D1AE82E551Q42785053-63114D12-875D-49C8-8B67-2C4713E25FECQ43061580-E3481B10-AE6E-40C8-BA35-41B4296C716EQ46077175-A7157CD2-810C-46D4-B3C2-676C43A6D842Q46881358-A9D97E06-958B-432C-A8D3-1A7D086F9375Q52667224-E3032E4B-1664-4FD2-A4FE-26C02055A796Q54964580-ED313F46-A508-40D2-919F-BEB0C6087E0FQ58710440-D9F048DF-5B1F-4A47-9794-DEFA6437A01C
P2860
Association between 5-lipoxygenase expression and plaque instability in humans.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Association between 5-lipoxygenase expression and plaque instability in humans.
@en
Association between 5-lipoxygenase expression and plaque instability in humans.
@nl
type
label
Association between 5-lipoxygenase expression and plaque instability in humans.
@en
Association between 5-lipoxygenase expression and plaque instability in humans.
@nl
prefLabel
Association between 5-lipoxygenase expression and plaque instability in humans.
@en
Association between 5-lipoxygenase expression and plaque instability in humans.
@nl
P2093
P1476
Association between 5-lipoxygenase expression and plaque instability in humans.
@en
P2093
Andrea Mezzetti
Annalisa Iezzi
Chiara Cuccurullo
Diana M Stafforini
Francesco Spigonardo
Franco Cuccurullo
Marco Bucci
Maria Luigia Fazia
Sante Ucchino
Stephen M Prescott
P304
P356
10.1161/01.ATV.0000172632.96987.2D
P407
P577
2005-06-02T00:00:00Z